Poteligeo Prices, Coupons, Copay Cards & Patient Assistance
Poteligeo (mogamulizumab) is a member of the miscellaneous antineoplastics drug class and is commonly used for Mycosis Fungoides.
The cost for Poteligeo (kpkc 4 mg/mL) intravenous solution is around $4,904 for a supply of 5 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Poteligeo prices
Intravenous Solution
kpkc 4 mg/mL
Poteligeo intravenous solution
from $4,904.17
for 5 milliliters
Quantity | Per unit | Price |
---|---|---|
5 milliliters | $980.83 | $4,904.17 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Poteligeo Coupons, Copay Cards and Rebates
Poteligeo offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Poteligeo Co-Pay Assistance Program
Eligible commercially insured patients may receive co-pay assistance.
- Applies to:
- Poteligeo
- Number of uses:
- Per prescription until program expires
Form more information phone: 833-552-2737 or Visit website
Poteligeo Medicare Part D Extra Help Program
Patients who have Medicare Part D coverage may be eligible to apply for the program and if accepted may receive reduced premiums and lower prescription costs.
- Applies to:
- Poteligeo
- Number of uses:
- Per prescription until program expires
Form more information phone: 800-633-4227 or Visit website
Patient Assistance & Copay Programs for Poteligeo
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Poteligeo (mogamulizumab-KPKC) Injection; IV
More information please phone: 866-316-7263 Visit Website
Provider: Kyowa Kirin Cares Patient Assistance Program: Poteligeo
Eligibility requirements:- Must be uninsured
- At or below 400% of FPL
- FDA-approved diagnosis
- The patient must also be permanently residing in the US or US territories.
- Co-payment assistance, and patient assistance programs are available for eligible patients.
- Poteligeo (mogamulizumab-KPKC) Injection; IV
More information please phone: 833-552-2737 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Poteligeo (mogamulizumab)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español